T1	Age 20 23	Age
E1	Age:T1
T2	Eq-Comparison 25 29	≥ 18
E2	Eq-Comparison:T2 Operator:T39 Value:T40
T3	Procedure 46 67	breast reconstruction
E3	Procedure:T3 Name:T41
T4	Modifier 94 100	breast
E4	Modifier:T4
T5	Condition 101 107	cancer
E5	Condition:T5 Name:T42
T6	Condition 109 121	precancerous
E6	Condition:T6 Name:T43
T7	Condition 122 129	lesions
E7	Condition:T7 Name:T44
T8	Condition 131 135	DCIS
E8	Condition:T8 Name:T45
T9	Condition 137 141	LCIS
E9	Condition:T9 Name:T46
T10	Condition 144 160	mutation carrier
E10	Condition:T10 Name:T47
T11	And 161 165	with
E11	And:T11
T12	Modifier 166 182	increased breast
E12	Modifier:T12
T13	Condition 183 189	cancer
E13	Condition:T13 Name:T49
T14	Risk 190 194	risk
E14	Risk:T14
T15	Family-Member 203 209	family
E15	Family-Member:T15
T16	Family-Member 210 217	history
E16	Family-Member:T16
T17	Observation 219 232	lifetime risk
E17	Observation:T17
T18	Eq-Comparison 233 238	> 15%
E18	Eq-Comparison:T18 Operator:T51 Value:T52 Unit:T53
T19	Assertion 255 265	capable to
E19	Assertion:T19
A1	Assertion-Type-Value E19 hypothetical
T20	Observation 286 323	aims and possible consequences of the
E20	Observation:T20
T21	Observation 324 338	clinical trial
E21	Observation:T21
T22	Eq-Comparison 340 351	MPG §20.2.1
E22	Eq-Comparison:T22 Value:T54
T23	Modifier 465 482	Metastatic breast
E23	Modifier:T23
T24	Condition 483 489	cancer
E24	Condition:T24 Name:T55
T25	Contraindication 509 526	contraindications
E25	Contraindication:T25
T26	Modifier 535 548	mesh-assisted
E26	Modifier:T26
T27	Or 549 551	or
E27	Or:T27
T28	Modifier 552 574	plastic-reconstructive
E28	Modifier:T28
T29	Procedure 575 581	breast
E29	Procedure:T29 Name:T57
T30	Procedure 582 589	surgery
E30	Procedure:T30 Name:T58
T31	Eq-Comparison 701 705	20.3
E31	Eq-Comparison:T31 Value:T60
T32	Other 722 729	another
E32	Other:T32
T33	Procedure 730 739	operative
E33	Procedure:T33
T34	Study 740 754	clinical trial
E34	Study:T34
T35	Procedure 785 814	reconstructive breast surgery
E35	Procedure:T35 Name:T61
T36	Or 815 821	and/or
E36	Or:T36
T37	Procedure 837 853	primary endpoint
E37	Procedure:T37
T38	Study 870 875	trial
E38	Study:T38
T39	Eq-Operator 25 26	≥
A2	Eq-Operator-Value T39 GTEQ
T40	Eq-Value 27 29	18
T41	Procedure-Name 46 67	breast reconstruction
T42	Condition-Name 101 107	cancer
T43	Condition-Name 109 121	precancerous
T44	Condition-Name 122 129	lesions
T45	Condition-Name 131 135	DCIS
T46	Condition-Name 137 141	LCIS
T47	Condition-Name 144 160	mutation carrier
T48	Polarity 166 175	increased
A3	Polarity-Value T48 high
T49	Condition-Name 183 189	cancer
T50	Eq-Temporal-Period 210 217	history
A4	Eq-Temporal-Period-Value T50 past
T51	Eq-Operator 233 234	>
A5	Eq-Operator-Value T51 GT
T52	Eq-Value 235 237	15
T53	Eq-Unit 237 238	%
T54	Eq-Value 345 351	20.2.1
T55	Condition-Name 483 489	cancer
T56	Procedure-Name 535 548	mesh-assisted
T57	Procedure-Name 575 581	breast
T58	Procedure-Name 582 589	surgery
T59	Observation-Name 649 675	institution under judicial
T60	Eq-Value 701 705	20.3
T61	Procedure-Name 800 814	breast surgery